Class Action Notice for Bath & Body Works Securities
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy BBWI?
Source: Globenewswire
- Class Action Notice: Rosen Law Firm reminds investors who purchased Bath & Body Works (NYSE: BBWI) securities between June 4, 2024, and November 19, 2025, that they must apply to be lead plaintiff by March 16, 2026, to participate in the class action and potentially receive compensation.
- Lawsuit Background: The lawsuit alleges that Bath & Body Works made materially false and misleading statements during the class period, failing to disclose that its strategy of 'adjacencies, collaborations, and promotions' was not effectively growing its customer base, resulting in investor losses.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has achieved the largest securities class action settlement against a Chinese company, being ranked first in 2017 for the number of settlements, showcasing its expertise and success in this field.
- Investor Guidance: Investors are advised to carefully select law firms with proven success in leadership roles, avoiding those that merely act as intermediaries, to ensure effective legal representation and support in the class action.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy BBWI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on BBWI
Wall Street analysts forecast BBWI stock price to fall
14 Analyst Rating
4 Buy
10 Hold
0 Sell
Moderate Buy
Current: 23.310
Low
15.00
Averages
20.14
High
26.00
Current: 23.310
Low
15.00
Averages
20.14
High
26.00
About BBWI
Bath & Body Works, Inc. is a global omnichannel retailer focused on personal care and home fragrance. The Company offers a range of fragrances for the body and home, including selling collections for 3-wick candles, home fragrance diffusers, fine fragrance mists, liquid hand soaps, body lotions and body creams. It delivers customers their fragrances in multiple forms and categories. The Company sells merchandise through its retail stores in the United States and Canada, and through its Websites and other channels, under the Bath & Body Works, White Barn and other brand names. The Company’s international business is conducted through franchise, license and wholesale partners. It provides in-store experiences at more than 1,890 Company-operated Bath & Body Works locations in the United States and Canada, more than 525 international franchised locations and an online storefront at bathandbodyworks.com. Additionally, it offers a buy online pick-up in-store (BOPIS) option.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Class Action Notice for Bath & Body Works Securities
- Class Action Notice: Rosen Law Firm reminds investors who purchased Bath & Body Works (NYSE: BBWI) securities between June 4, 2024, and November 19, 2025, that they must apply to be lead plaintiff by March 16, 2026, to participate in the class action and potentially receive compensation.
- Lawsuit Background: The lawsuit alleges that Bath & Body Works made materially false and misleading statements during the class period, failing to disclose that its strategy of 'adjacencies, collaborations, and promotions' was not effectively growing its customer base, resulting in investor losses.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has achieved the largest securities class action settlement against a Chinese company, being ranked first in 2017 for the number of settlements, showcasing its expertise and success in this field.
- Investor Guidance: Investors are advised to carefully select law firms with proven success in leadership roles, avoiding those that merely act as intermediaries, to ensure effective legal representation and support in the class action.
See More
Key Earnings Reports and Economic Data Next Week
- Earnings Reports: Next week will feature earnings releases from Berkshire Hathaway (BRK-B, BRK-A), which are expected to significantly impact market sentiment, particularly as investors focus on the performance of its investment portfolio.
- Retail Giants' Earnings: Companies like Costco (COST), Target (TGT), Okta (OKTA), and Broadcom (AVGO) will report earnings next week, providing critical insights into consumer spending and the health of the tech sector, which could influence stock valuations.
- Employment Data Release: February's jobs report is set to be released on March 6, with the market keenly watching for changes in job growth and unemployment rates, which will impact the Federal Reserve's monetary policy decisions.
- Federal Reserve Commentary: Additionally, commentary from regional Federal Reserve bank presidents will be available next week, and the market will closely monitor their views on the economic outlook to assess potential future interest rate policies.
See More
Bath & Body Works Launches Limited-Time PEEPS® Collaboration for Spring
- Limited Edition Collaboration: Bath & Body Works is launching a limited-time collection in collaboration with PEEPS®, covering body care, home fragrance, and accessories, aimed at adding color and fun to spring and Easter celebrations, which is expected to attract significant consumer interest.
- Unique Fragrance Experience: The new scent, “Peepin' It Real,” blends fluffy marshmallow, sugar crystals, and whipped vanilla to deliver a true-to-life fragrance experience, further solidifying Bath & Body Works' leadership in the gourmand fragrance market.
- Member-Exclusive Launch: The collection will be available online to loyalty members starting March 1, with a broader release to all consumers on March 2, which is anticipated to drive sales growth and enhance customer loyalty.
- Diverse Product Line: The new collection includes body cream, body wash, fragrance mist, candles, and more, catering to various consumer needs for gifting and celebrations during spring, thereby enhancing the brand's market competitiveness.
See More
Faruqi & Faruqi Investigates Bath & Body Works Securities Claims
- Legal Investigation Launched: Faruq & Faruq LLP is investigating potential securities fraud claims against Bath & Body Works (NYSE:BBWI), specifically urging investors who purchased securities between June 4, 2024, and November 19, 2025, to contact them before the March 16, 2026 deadline to seek lead plaintiff status.
- Disappointing Financial Performance: On November 20, 2025, Bath & Body Works reported a 1% year-over-year decline in revenue for Q3, missing the 1-3% growth guidance, and a significant 26% drop in net income to $77 million, leading to a drastic reduction in full-year earnings guidance from a range of $3.28 to $3.53 per share to at least $2.83.
- Strategic Missteps Revealed: The company acknowledged that its strategy focused on
See More
Class Action Lawsuit Filed Against Bath & Body Works
- Class Action Initiated: Pomerantz LLP has filed a class action lawsuit against Bath & Body Works, alleging securities fraud and other unlawful business practices, with investors needing to apply as Lead Plaintiff by March 16, 2026.
- Poor Financial Results: In Q2 2025, Bath & Body Works reported earnings per diluted share of $0.30, a 55.8% year-over-year decline, missing prior guidance by $0.03, with net income falling to $64 million, down 57.9% year-over-year.
- Guidance Cut: The company lowered its full-year earnings guidance to a range of $3.28 to $3.53, resulting in a 6.9% stock price drop to $29.36 on August 28, 2025, reflecting investor concerns over performance.
- Q3 Revenue Decline: In Q3 2025, revenue declined by 1% year-over-year, missing the 1-3% growth guidance, with net income down 26% to $77 million, leading to a 24.8% stock price drop to $15.82 due to negative outlooks.
See More
Reminder of Shareholder Class Action Lawsuits
- Defendant Overview: CoreWeave, Inc. (CRWV) is accused of making false or misleading statements regarding its ability to meet customer demand between March 28, 2025, and December 15, 2025, with affected investors encouraged to seek lead plaintiff status by March 13, 2026.
- Customer Growth Allegations: Bath & Body Works, Inc. (BBWI) faces allegations of failing to disclose material facts about its customer base and net sales growth from June 4, 2024, to November 19, 2025, prompting affected investors to contact legal counsel before the March 13, 2026 deadline.
- Clinical Trial Risks: Vistagen Therapeutics, Inc. (VTGN) is involved in a lawsuit for not disclosing risks associated with its Phase 3 PALISADE-3 trial between April 1, 2024, and December 16, 2025, with a deadline of March 16, 2026, for investors to apply for lead plaintiff status.
- Law Firm Background: Holzer & Holzer, LLC, recognized as a top-rated securities litigation firm, has been dedicated to representing shareholders since 2000, recovering hundreds of millions for investors affected by corporate misconduct, highlighting its significant role in the legal landscape.
See More
Class Action Notice for Bath & Body Works Securities
- Class Action Notice: Rosen Law Firm reminds investors who purchased Bath & Body Works (NYSE: BBWI) securities between June 4, 2024, and November 19, 2025, that they must apply to be lead plaintiff by March 16, 2026, to participate in the class action and potentially receive compensation.
- Lawsuit Background: The lawsuit alleges that Bath & Body Works made materially false and misleading statements during the class period, failing to disclose that its strategy of 'adjacencies, collaborations, and promotions' was not effectively growing its customer base, resulting in investor losses.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has achieved the largest securities class action settlement against a Chinese company, being ranked first in 2017 for the number of settlements, showcasing its expertise and success in this field.
- Investor Guidance: Investors are advised to carefully select law firms with proven success in leadership roles, avoiding those that merely act as intermediaries, to ensure effective legal representation and support in the class action.
See More
Key Earnings Reports and Economic Data Next Week
- Earnings Reports: Next week will feature earnings releases from Berkshire Hathaway (BRK-B, BRK-A), which are expected to significantly impact market sentiment, particularly as investors focus on the performance of its investment portfolio.
- Retail Giants' Earnings: Companies like Costco (COST), Target (TGT), Okta (OKTA), and Broadcom (AVGO) will report earnings next week, providing critical insights into consumer spending and the health of the tech sector, which could influence stock valuations.
- Employment Data Release: February's jobs report is set to be released on March 6, with the market keenly watching for changes in job growth and unemployment rates, which will impact the Federal Reserve's monetary policy decisions.
- Federal Reserve Commentary: Additionally, commentary from regional Federal Reserve bank presidents will be available next week, and the market will closely monitor their views on the economic outlook to assess potential future interest rate policies.
See More
Bath & Body Works Launches Limited-Time PEEPS® Collaboration for Spring
- Limited Edition Collaboration: Bath & Body Works is launching a limited-time collection in collaboration with PEEPS®, covering body care, home fragrance, and accessories, aimed at adding color and fun to spring and Easter celebrations, which is expected to attract significant consumer interest.
- Unique Fragrance Experience: The new scent, “Peepin' It Real,” blends fluffy marshmallow, sugar crystals, and whipped vanilla to deliver a true-to-life fragrance experience, further solidifying Bath & Body Works' leadership in the gourmand fragrance market.
- Member-Exclusive Launch: The collection will be available online to loyalty members starting March 1, with a broader release to all consumers on March 2, which is anticipated to drive sales growth and enhance customer loyalty.
- Diverse Product Line: The new collection includes body cream, body wash, fragrance mist, candles, and more, catering to various consumer needs for gifting and celebrations during spring, thereby enhancing the brand's market competitiveness.
See More
Faruqi & Faruqi Investigates Bath & Body Works Securities Claims
- Legal Investigation Launched: Faruq & Faruq LLP is investigating potential securities fraud claims against Bath & Body Works (NYSE:BBWI), specifically urging investors who purchased securities between June 4, 2024, and November 19, 2025, to contact them before the March 16, 2026 deadline to seek lead plaintiff status.
- Disappointing Financial Performance: On November 20, 2025, Bath & Body Works reported a 1% year-over-year decline in revenue for Q3, missing the 1-3% growth guidance, and a significant 26% drop in net income to $77 million, leading to a drastic reduction in full-year earnings guidance from a range of $3.28 to $3.53 per share to at least $2.83.
- Strategic Missteps Revealed: The company acknowledged that its strategy focused on
See More
Class Action Lawsuit Filed Against Bath & Body Works
- Class Action Initiated: Pomerantz LLP has filed a class action lawsuit against Bath & Body Works, alleging securities fraud and other unlawful business practices, with investors needing to apply as Lead Plaintiff by March 16, 2026.
- Poor Financial Results: In Q2 2025, Bath & Body Works reported earnings per diluted share of $0.30, a 55.8% year-over-year decline, missing prior guidance by $0.03, with net income falling to $64 million, down 57.9% year-over-year.
- Guidance Cut: The company lowered its full-year earnings guidance to a range of $3.28 to $3.53, resulting in a 6.9% stock price drop to $29.36 on August 28, 2025, reflecting investor concerns over performance.
- Q3 Revenue Decline: In Q3 2025, revenue declined by 1% year-over-year, missing the 1-3% growth guidance, with net income down 26% to $77 million, leading to a 24.8% stock price drop to $15.82 due to negative outlooks.
See More
Reminder of Shareholder Class Action Lawsuits
- Defendant Overview: CoreWeave, Inc. (CRWV) is accused of making false or misleading statements regarding its ability to meet customer demand between March 28, 2025, and December 15, 2025, with affected investors encouraged to seek lead plaintiff status by March 13, 2026.
- Customer Growth Allegations: Bath & Body Works, Inc. (BBWI) faces allegations of failing to disclose material facts about its customer base and net sales growth from June 4, 2024, to November 19, 2025, prompting affected investors to contact legal counsel before the March 13, 2026 deadline.
- Clinical Trial Risks: Vistagen Therapeutics, Inc. (VTGN) is involved in a lawsuit for not disclosing risks associated with its Phase 3 PALISADE-3 trial between April 1, 2024, and December 16, 2025, with a deadline of March 16, 2026, for investors to apply for lead plaintiff status.
- Law Firm Background: Holzer & Holzer, LLC, recognized as a top-rated securities litigation firm, has been dedicated to representing shareholders since 2000, recovering hundreds of millions for investors affected by corporate misconduct, highlighting its significant role in the legal landscape.
See More
